These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 37614952
41. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. Geller JL, Hu B, Reed S, Mirocha J, Adams JS. Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035 [Abstract] [Full Text] [Related]
44. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD. Chubachi S, Nakamura H, Sasaki M, Haraguchi M, Miyazaki M, Takahashi S, Tanaka K, Funatsu Y, Asano K, Betsuyaku T, Keio COPD Comorbidity Research (K-CCR) Group. Respirology; 2015 Feb; 20(2):286-95. PubMed ID: 25392953 [Abstract] [Full Text] [Related]
46. Discordance in lumbar bone mineral density measurements by quantitative computed tomography and dual-energy X-ray absorptiometry in postmenopausal women: a prospective comparative study. Lin W, He C, Xie F, Chen T, Zheng G, Yin H, Chen H, Wang Z. Spine J; 2023 Feb; 23(2):295-304. PubMed ID: 36343911 [Abstract] [Full Text] [Related]
47. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, Hoffmann ME, Tebas P. J Acquir Immune Defic Syndr; 2005 Apr 01; 38(4):426-31. PubMed ID: 15764959 [Abstract] [Full Text] [Related]
49. Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan. Lin CH, Chen KH, Chen CM, Chang CH, Huang TJ, Lin CH. PeerJ; 2018 Apr 01; 6():e4232. PubMed ID: 29340241 [Abstract] [Full Text] [Related]
50. The Association of Bone Mineral Density with Mortality in a COPD Cohort. The HUNT Study, Norway. Vikjord SAA, Brumpton BM, Mai XM, Bhatta L, Vanfleteren L, Langhammer A. COPD; 2019 Dec 01; 16(5-6):321-329. PubMed ID: 31709837 [Abstract] [Full Text] [Related]
52. Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study. Doria C, Leali PT, Solla F, Maestretti G, Balsano M, Scarpa RM. Clin Cases Miner Bone Metab; 2016 Dec 01; 13(3):195-199. PubMed ID: 28228781 [Abstract] [Full Text] [Related]
53. Bone mineral density in emphysema and chronic bronchitis phenotypes in hospitalized male chronic obstructive pulmonary disease patients. Yormaz B, Cebeci H, Yılmaz F, Süerdem M. Clin Respir J; 2020 Jan 01; 14(1):47-53. PubMed ID: 31628822 [Abstract] [Full Text] [Related]
54. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort. Segaud N, Legroux I, Hazzan M, Noel C, Cortet B. Osteoporos Int; 2018 May 01; 29(5):1165-1175. PubMed ID: 29500526 [Abstract] [Full Text] [Related]
55. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis. Iwamoto J, Takeda T, Sato Y, Uzawa M. Yonsei Med J; 2004 Aug 31; 45(4):676-82. PubMed ID: 15344210 [Abstract] [Full Text] [Related]
56. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Vondracek SF, Voelkel NF, McDermott MT, Valdez C. Int J Chron Obstruct Pulmon Dis; 2009 Aug 31; 4():267-77. PubMed ID: 19657401 [Abstract] [Full Text] [Related]